Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 806

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 806
---
 at December 31, 2024 |     | 1,598,962 |   |

The intrinsic value of exercisable but unexercised in -the-moneycommon share warrants at December 31, 2024 was $ 344,802. Option Plan On December 14, 2021, the Board of Directors adopted the Share Option Plan Regulation 2021 (the “Option Plan”). The purpose of the Option Plan is to retain, attract and motivate management, employees, directors and consultants by providing them with options to purchase the Company’s common shares. The Board of Directors allocated fifteen percent ( 15%) of the Company’s fully diluted shares to awards that may be made pursuant to the Option Plan. The exercise prices, vesting and other restrictions of the awards to be granted under the Option Plan are determined by the Board of Directors, except that no stock option may be issued with an exercise price less than the fair market value of the common shares at the date of the grant or have a term in excess of tenyears. Options granted under the Option Plan are exercisable in whole or in part at any time subsequent to vesting.

Annex F-24 NLS PHARMACEUTICS LTD. AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

The following table summarizes total stock option activity for the year ended December 31, 2024:

|                                                     |     | Number of 
   Options |   |     | Weighted 
 Average  
 Exercise 
 Price    |       |
|:----------------------------------------------------|:----|----------:|:--|:----|:---------|------:|
| Balance at December 31, 2022                        |     |    33,328 |   |     | $        | 49.20 |
| Granted                                             |     |    19,409 |   |     |          | 30.40 |
| Exercised                                           |     |         — |   |     |          |       |
| Expired/cancelled                                   |     |    (6,145 | ) |     |          | 39.60 |
| Balance at December 31, 2023                        |     |    46,591 |   |     | $        | 42.74 |
| Granted                                             |     |         — |   |     |          |     — |
| Exercised                                           |     |         — |   |     |          |     — |
| Expired/cancelled